Latest

Understand ALK fusion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

ALK Fusion Test for Lung Cancer: Gene Fusion, Positive Result, and Molecular Meaning

Understand BRAF V600E testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

BRAF V600E Test for Lung Cancer: Mutation Status, Positive Result, and Molecular Meaning

Learn how the carcinoembryonic antigen (CEA) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CEA Test for Lung Cancer: Tumor Marker Monitoring, High Levels, and Result Meaning

Learn how the cytokeratin 19 fragment 21-1 (CYFRA 21-1) test is used in lung cancer, what high levels can mean, common non-cancer causes, reference ranges, and why serial trends matter.

CYFRA 21-1 Test for Lung Cancer: Tumor Marker Levels and Disease Monitoring

Understand EGFR exon 20 insertion testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Exon 20 Insertion Test: Lung Cancer Mutation Status and Molecular Meaning

Understand EGFR mutation testing in lung cancer, including what a positive or negative result means, tissue and ctDNA methods, limitations, and treatment relevance.

EGFR Mutation Test for Lung Cancer: Exon 19, L858R, T790M, Mutation Status, and...

Diagnostics

Home Diagnostics Page 40

Understand what a pharmacogenetic panel test measures, which medication-response genes may be actionable, how results are interpreted, and how panels can guide safer prescribing.

Pharmacogenetic Panel Test: Medication Response, Gene Variants, and Results

Learn what psychiatric pharmacogenetic testing can and cannot predict for antidepressants and antipsychotics, including CYP2D6, CYP2C19, SLC6A4, results, limits, and safe treatment use.

Psychiatric Pharmacogenetic Test: Antidepressants, Antipsychotics, Genes, and Results

Learn how RYR1 genetic testing evaluates malignant hyperthermia susceptibility, what positive, negative, and uncertain results mean, and how to plan safe trigger-free anesthesia.

RYR1 Genetic Test: Malignant Hyperthermia Risk and Anesthesia Results

Understand SLC6A4 genetic testing, 5-HTTLPR and rs25531 results, the evidence on SSRI response, why guidelines do not recommend stand-alone prescribing changes, and how to use findings safely.

SLC6A4 Genetic Test: Antidepressant Response, Serotonin Transporter, and Results

Learn what an SLCO1B1 genetic test reveals about simvastatin exposure and statin muscle-risk, how results are reported, and how clinicians may use them safely.

SLCO1B1 Genetic Test: Statin Muscle Risk, Simvastatin, and Results

Understand how a statin pharmacogenetic test uses SLCO1B1, ABCG2, and CYP2C9 results to assess muscle-risk and guide safer, effective statin choices.

Statin Pharmacogenetic Test: SLCO1B1, Muscle Pain Risk, and Results

Learn how CYP3A5 pharmacogenetic testing can guide an initial tacrolimus dose after transplant, how results are interpreted, and why trough monitoring remains essential.

Tacrolimus Pharmacogenetic Test: CYP3A5, Dose, Transplant, and Results

Learn how TPMT and NUDT15 pharmacogenetic testing predicts thiopurine toxicity risk, guides safer starting doses, and works with ongoing blood-count monitoring.

Thiopurine Pharmacogenetic Test: TPMT, NUDT15, Toxicity Risk, and Results

Learn how a TPMT genetic test predicts azathioprine and mercaptopurine toxicity risk, how metabolizer results guide starting doses, and why NUDT15 and blood monitoring still matter.

TPMT Genetic Test: Thiopurine Toxicity, Azathioprine, Mercaptopurine, and Results

Learn how UGT1A1 testing can predict irinotecan toxicity risk, support a Gilbert syndrome diagnosis, and clarify the meaning of *28, *6, and metabolizer results.

UGT1A1 Genetic Test: Irinotecan Toxicity, Gilbert Syndrome, and Results

Learn how a VKORC1 genetic test predicts warfarin sensitivity, what G/G, G/A, and A/A results mean, and why dosing still requires CYP2C9 data and INR monitoring.

VKORC1 Genetic Test: Warfarin Sensitivity, Dose, and Results

Understand how a warfarin pharmacogenetic test uses CYP2C9, VKORC1, CYP4F2, and ancestry-aware results to estimate dose while INR monitoring guides safe treatment.

Warfarin Pharmacogenetic Test: CYP2C9, VKORC1, CYP4F2, Dose, and Results

Understand Alzheimer disease genetic testing for APOE, APP, PSEN1, and PSEN2, including who should test, result meanings, family risk, and treatment safety.

Alzheimer Disease Genetic Test: APOE, APP, PSEN1, PSEN2, and Results

Learn how ALS genetic testing evaluates C9orf72, SOD1, TARDBP, FUS, and other genes, what results mean, and how findings can affect treatment and family risk.

Amyotrophic Lateral Sclerosis (ALS) Genetic Test: C9orf72, SOD1, TARDBP, and Results

Understand Angelman syndrome genetic testing for UBE3A, methylation, deletions, uniparental disomy, and imprinting defects, including results and recurrence risk.

Angelman Syndrome Genetic Test: UBE3A, Methylation, Deletion, and Results

Learn what an APOE genotype test shows about Alzheimer disease risk, cholesterol disorders, anti-amyloid treatment safety, and ε2, ε3, and ε4 results.

APOE Genotype Test: Alzheimer Disease Risk, Cholesterol, and Results

Learn how chromosomal microarray, exome sequencing, genome sequencing, and targeted tests are used in autism, what results mean, and how findings may guide care.

Autism Genetic Testing: Chromosomal Microarray, Exome Sequencing, and Results

Learn how Becker muscular dystrophy genetic testing detects DMD deletions, duplications, and sequence variants, and what results mean for weakness, heart care, and family risk.

Becker Muscular Dystrophy Genetic Test: DMD Gene, Muscle Weakness, and Results

Understand how C9orf72 repeat expansion testing relates to ALS and frontotemporal dementia, how results are classified, and what they mean for family risk.

C9orf72 Genetic Test: ALS, Frontotemporal Dementia, and Results

Learn how Charcot-Marie-Tooth genetic testing evaluates PMP22, GJB1, MFN2, MPZ, copy-number changes, inheritance, and positive, negative, or uncertain results.

Charcot-Marie-Tooth Disease Genetic Test: PMP22, GJB1, MFN2, MPZ, and Results

1...394041...93 Page 40 of 93